Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Elevated blood pressure (BP) consists of a major public health concern especially in low and
middle income countries. Besides being a highly prevalent condition, it is also a risk factor
for several major cardiovascular events including stroke (which consists of the second
leading cause of death in developing countries) and coronary artery disease, and is also
related to cognitive decline. The OPTIMAL Stroke trial consists of a two-arm, multicenter,
randomized clinical trial designed to test whether a lower target systolic blood pressure
(SBP) as compared to the currently recommended target for stroke patients will reduce the
occurrence of major cardiovascular events.